Lv23
170 积分 2023-07-11 加入
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
1天前
待确认
Current understanding and management of CAR T cell-associated toxicities
1天前
已完结
The present and future for CAR-T cell therapy in adult B-cell ALL
1天前
已完结
The present and future for CAR-T cell therapy in adult B-cell ALL
1天前
已关闭
Cancer immunotherapy by γδ T cells
20天前
已完结
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma
1个月前
已完结
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma
1个月前
已关闭
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma
1个月前
已关闭
An integrated perspective on measuring cytokines to inform CAR-T bioprocessing
2个月前
已完结
Metabolic engineering for optimized CAR-T cell therapy
2个月前
已完结
皖公网安备34019202002308
